Filing Details
- Accession Number:
- 0001209191-20-046064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-11 12:21:29
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-11 12:21:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-07 | 5,904 | $40.37 | 18,204 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-07 | 17,500 | $21.00 | 35,704 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-07 | 23,404 | $85.55 | 12,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-10 | 9,750 | $85.01 | 2,550 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-08-10 | 1,596 | $40.37 | 4,146 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-10 | 1,596 | $85.01 | 2,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-07 | 5,904 | $0.00 | 5,904 | $40.37 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-07 | 17,500 | $0.00 | 17,500 | $21.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-10 | 1,596 | $0.00 | 1,596 | $40.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,596 | 2024-07-09 | No | 4 | M | Direct | |
| 0 | 2024-01-29 | No | 4 | M | Direct | |
| 0 | 2024-07-09 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $87.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- The option vested in full on June 18, 2015.
- The option vested with respect to 1/36th of the shares monthly such that the option fully vested on January 30, 2017.
Billionaire Hedge Funds
